These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9631887)

  • 1. Reduced number of circulating monocytes after institution of insulin therapy--relevance for development of atherosclerosis in diabetics?
    Persson SU; Larsson H; Odeberg H
    Angiology; 1998 Jun; 49(6):423-33. PubMed ID: 9631887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood viscosity and erythrocyte filterability: their evaluation in diabetes mellitus.
    Caimi G
    Horm Metab Res; 1983 Oct; 15(10):467-70. PubMed ID: 6642407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetics with higher plasma viscosity exhibit a higher blood pressure.
    Brun JF; Aloulou I; Varlet-Marie E
    Clin Hemorheol Microcirc; 2004; 30(3-4):365-72. PubMed ID: 15258368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of hyperinsulinemia in the immunopathogenesis of atherosclerosis in diabetics].
    Krasil'nikova EI; Freĭdlin IS
    Patol Fiziol Eksp Ter; 1991; (4):41-3. PubMed ID: 1798652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are rheological markers of poor prognosis present in diabetic arteriopathies?].
    Boisseau MR
    J Mal Vasc; 2001 Apr; 26(2):117-21. PubMed ID: 11319417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus.
    Coppola L; Verrazzo G; La Marca C; Ziccardi P; Grassia A; Tirelli A; Giugliano D
    Diabet Med; 1997 Nov; 14(11):959-63. PubMed ID: 9400920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oral hypoglycemic agents in therapy and prevention of macrovascular complications.
    Krall LP
    Horm Metab Res Suppl; 1985; 15():98-101. PubMed ID: 3908284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheological leukocyte indexes in diabetes mellitus type II.
    Perego MA; Danese C; Volpe MS; Zavattaro E; Calisi L
    Ann Cardiol Angeiol (Paris); 1992 Dec; 41(10):A75-80. PubMed ID: 1300912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte flow properties, polymorphonuclear membrane fluidity, and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease with and without noninsulin-dependent diabetes mellitus.
    Caimi G; Canino B; Ferrara F; Montana M; Meli F; Catania A; Lo presti R
    Angiology; 1996 Aug; 47(8):757-63. PubMed ID: 8712478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The characteristics of the peripheral blood monocytes in diabetics].
    Galenok VA; Zhuk EA
    Ter Arkh; 1997; 69(2):59-62. PubMed ID: 9173581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorheology and vascular reactivity in patients with diabetes mellitus type 2.
    Velcheva I; Damianov P; Antonova N; Stoyneva Z; Mantarova S; Dimitrova V
    Clin Hemorheol Microcirc; 2011; 49(1-4):505-11. PubMed ID: 22214721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood and plasma viscosity and the distance of intermittent claudication in patients with type II diabetes and thrombophlebitis].
    Turczyński B; Sroczyński J; Matyszczyk B; Szczesny S; Strugala M
    Wiad Lek; 1990 Jun; 43(11):483-8. PubMed ID: 2219912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications.
    Corrales JJ; Almeida M; Burgo RM; Hernández P; Miralles JM; Orfao A
    J Diabetes Complications; 2007; 21(1):41-9. PubMed ID: 17189873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
    Tkác I; Tkácová R; Takác M; Lazúr J
    Vasa; 1992; 21(4):360-4. PubMed ID: 1485469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.